Alzheimer's disease A4 peptide oligomer (A-beta oligomer, A-beta derived diffusable ligand, ADDL)

From Aaushi
Jump to navigation Jump to search

Function

Structure

Pathology

More general terms

More specific terms

Additional terms

References

  1. Gilbert BJ. The role of amyloid beta in the pathogenesis of Alzheimer's disease. J Clin Pathol. 2013 May;66(5):362-6 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23526599
  2. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci. 2004 Nov 10;24(45):10191-200. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15537891
  3. 3.0 3.1 Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci. 2005 Jan;8(1):79-84. Epub 2004 Dec 19. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15608634
  4. 4.0 4.1 McLaurin J, Kierstead ME, Brown ME, Hawkes CA, Lambermon MH, Phinney AL, Darabie AA, Cousins JE, French JE, Lan MF, Chen F, Wong SS, Mount HT, Fraser PE, Westaway D, George-Hyslop PS. Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat Med. 2006 Jul;12(7):801-8. Epub 2006 Jun 11. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16767098
  5. 5.0 5.1 Lauren J et al. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-oligomers. Nature 2009 Feb 26; 457:1128 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19242475
    Cisse M and Mucke L. Alzheimer's disease: A prion protein connection. Nature 2009 Feb 26; 457:1090. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19242462